ENSG00000093072


Homo sapiens

Features
Gene ID: ENSG00000093072
  
Biological name :ADA2
  
Synonyms : ADA2 / adenosine deaminase 2 / Q9NZK5
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 22
Strand: -1
Band: q11.1
Gene start: 17178790
Gene end: 17221989
  
Corresponding Affymetrix probe sets: 219505_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000392078
Ensembl peptide - ENSP00000382733
Ensembl peptide - ENSP00000406443
Ensembl peptide - ENSP00000483418
Ensembl peptide - ENSP00000442482
Ensembl peptide - ENSP00000262607
Ensembl peptide - ENSP00000332871
Ensembl peptide - ENSP00000382731
NCBI entrez gene - 51816     See in Manteia.
OMIM - 607575
RefSeq - XM_011546133
RefSeq - NM_001282225
RefSeq - NM_001282226
RefSeq - NM_001282227
RefSeq - NM_001282228
RefSeq - NM_001282229
RefSeq - NM_177405
RefSeq - XM_006724080
RefSeq Peptide - NP_001269154
RefSeq Peptide - NP_001269156
RefSeq Peptide - NP_001269157
RefSeq Peptide - NP_001269158
RefSeq Peptide - NP_803124
RefSeq Peptide - NP_001269155
swissprot - B4E3Q4
swissprot - A0A087X0I3
swissprot - C9IZA8
swissprot - Q9NZK5
swissprot - F5H7J3
Ensembl - ENSG00000093072
  
Related genetic diseases (OMIM): 182410 - ?Sneddon syndrome, 182410
  615688 - Polyarteritis nodosa, childhood-onset, 615688
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 ada2aENSDARG00000051746Danio rerio
 ada2bENSDARG00000015623Danio rerio
 CECR1ENSGALG00000013031Gallus gallus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
No match


Protein motifs (from Interpro)
Interpro ID Name
 IPR001365  Adenosine/AMP deaminase domain
 IPR006331  Adenosine deaminase-related growth factor
 IPR013659  Adenosine/AMP deaminase N-terminal
 IPR032466  Metal-dependent hydrolase


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006154 adenosine catabolic process IDA
 biological_processGO:0007275 multicellular organism development NAS
 biological_processGO:0010469 regulation of signaling receptor activity IEA
 biological_processGO:0043103 hypoxanthine salvage IBA
 biological_processGO:0043312 neutrophil degranulation TAS
 biological_processGO:0044267 cellular protein metabolic process TAS
 biological_processGO:0046103 inosine biosynthetic process IBA
 cellular_componentGO:0005576 extracellular region TAS
 cellular_componentGO:0005615 extracellular space IDA
 cellular_componentGO:0035578 azurophil granule lumen TAS
 molecular_functionGO:0004000 adenosine deaminase activity TAS
 molecular_functionGO:0008083 growth factor activity IBA
 molecular_functionGO:0008201 heparin binding IEA
 molecular_functionGO:0008270 zinc ion binding IDA
 molecular_functionGO:0016787 hydrolase activity IEA
 molecular_functionGO:0019239 deaminase activity IEA
 molecular_functionGO:0031685 adenosine receptor binding IDA
 molecular_functionGO:0042803 protein homodimerization activity IPI
 molecular_functionGO:0043394 proteoglycan binding IDA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
Surfactant metabolism
Neutrophil degranulation


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000112 Nephropathy "A nonspecific term referring to disease or damage of the kidneys." [HPO:curators]
Show

 HP:0000602 Ophthalmoplegia 
Show

 HP:0000648 Optic atrophy 
Show

 HP:0000708 Behavioural/Psychiatric Abnormality 
Show

 HP:0000713 Agitation 
Show

 HP:0000726 Dementia 
Show

 HP:0000822 Hypertension "High blood pressure." [HPO:curators]
Show

 HP:0000965 Cutis marmorata 
Show

 HP:0000979 Purpura 
Show

 HP:0001123 Visual field defects 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001251 Ataxia "Ataxia is a nonspecific neurological sign and symptom consisting of gross lack of coordination of muscle movements. Ataxia is caused by dysfunction of one or more parts of the nervous system including the cerebellum, the sensory nervous system, the vestibular system, or the cerebral cortex." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001268 Mental deterioration 
Show

 HP:0001269 Hemiparesis "Relatively mild weakness in the arm, leg, and in some cases the face on one side of the body." [HPO:curators]
Show

 HP:0001270 Motor retardation 
Show

 HP:0001297 Stroke 
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001337 Tremor "An unintentional, oscillating to-and-fro muscle movement." [HPO:curators]
Show

 HP:0001369 Arthritis 
Show

 HP:0001727 Thromboembolic stroke may occur 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001882 Leukopenia 
Show

 HP:0001894 Thrombocytosis 
Show

 HP:0001903 Anemia 
Show

 HP:0001945 Fever 
Show

 HP:0001974 Leukocytosis "An abnormal increase in the number of `leukocytes` (CL:0000738) in the `blood` (FMA:9670)." [HPO:probinson]
Show

 HP:0002027 Abdominal pain 
Show

 HP:0002072 Chorea "Chorea (Greek for dance ) refers to widespread arrhythmic involuntary movements of a forcible, jerky and restless fashion." [HPO:curators]
Show

 HP:0002076 Migraine 
Show

 HP:0002170 Intracranial hemorrhage "A hemorrhage (bleeding) occuring within the skull." [HPO:curators]
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002301 Hemiplegia "Paralysis (complete loss of muscle function) in the arm, leg, and in some cases the face on one side of the body." [HPO:curators]
Show

 HP:0002315 Headache "Cephalgia, or pain in the head originating from the cerebral vault." [HPO:curators]
Show

 HP:0002321 Vertigo "An abnormal sensation of spinning while the body is actually stationary." [HPO:curators]
Show

 HP:0002354 Memory impairment 
Show

 HP:0002376 Developmental regression 
Show

 HP:0002381 Aphasia 
Show

 HP:0002617 Aneurysm 
Show

 HP:0002721 Immunodeficiency 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003326 Myalgia "A tendency to experience muscle pain." [HPO:curators]
Show

 HP:0003613 Phospholipid antibody positive 
Show

 HP:0003676 Progressive disorder 
Show

 HP:0003745 Sporadic 
Show

 HP:0003828 Variable expressivity 
Show

 HP:0004313 Reduced immunoglobulin levels 
Show

 HP:0009830 Peripheral neuropathy "Peripheral neuropathy is a general term for any disorder of the peripheral nervous system. The main clinical features used to classify peripheral neuropathy are distribution, type (mainly demyelinating versus mainly axonal), duration, and course." [HPO:curators]
Show

 HP:0010628 Facial muscle weakness "A weakness of any or all of the muscles of the face of any etiology." [HPO:curators]
Show

 HP:0012219 Erythema nodosum "An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral." [HPO:probinson]
Show

 HP:0012490 Panniculitis "Inflammation of `adipose tissue` (FMA)20110)." [HPO:probinson]
Show

 HP:0025343 Lupus anticoagulant "Presence of lupus anticoagulant (LA) autoantiboides. LA represent a heterogeneous group of autoantibodies, IgG, IgM, or a mixture of both classes, that interfere with standard phospholipid-based coagulant tests (this is only an in vitro phenomenon, LA do not cause reduction of coagulation in vivo). The antibodies are directed against plasma proteins which also bind to phospholipid surfaces." []
Show

 HP:0030880 Raynaud phenomenon 
Show

 HP:0100545 Arterial stenosis 
Show

 HP:0100576 Amaurosis fugax "A transient visual disturbance that is typically caused by a circulatory, ocular or neurological underlying condition." [HPO:sdoelken]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000093072 ADA2 / Q9NZK5 / adenosine deaminase 2  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2025
contact: otassy@igbmc.fr